Role of β-Adrenergic Signal Transduction Pathway on Myocardial Ischemic Preconditioning of Rats

被引:0
|
作者
兰晓莉 [1 ]
王军 [2 ]
张永学 [1 ]
机构
[1] Department of Nuclear Medcine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430022, China
[2] No.1 Ranking Department, General Hospital of Shenyang Military Area, Shenyang 110015, China
关键词
ischemic preconditioning; myocardial; receptors; adrenergic beta; cyclic AMP; cyclic AMP-dependent protein kinase; rat;
D O I
暂无
中图分类号
R542.2 [心肌疾病];
学科分类号
1002 ; 100201 ;
摘要
To study the changes in every part of the β-adrenergic signal transduction pathway and their effects on ischemic preconditioning of rat myocardium in vivo. SD rats were divided into three groups: IP group, I/R group and CON group. The IP group was further divided into PC1-, 2-, 3-, and PC1+, 2+, 3+ groups according to preconditioning procedure. The rats received surgical procedure and underwent left coronary artery occlusion and reperfusion. We analyzed the infarct size by TTC staining, measured serum myocardial enzymes, studied the β-AR Bmax and Kd by radioligand binding assay of receptors, checked the activity of AC and PKA by the method of biochemistry and examined the content of cAMP by radioimmunoassay. The infarct area was much smaller in the IP group than in the I/R group (P<0.001), while the enzymes were significantly higher in I/R (P<0.001). The Bmax of β-AR in IP was much higher than that in I/R (P<0.001), but no difference in Kd could be seen between IP and I/R groups. In IP, the activity of AC and PKA and the content of cAMP were higher than those in I/R (P<0.05, 0.002 and 0.001, respectively). In the procedure of preconditioning, the content of cAMP and the activity of PKA showed the characteristic of cyclic fluctuation. Ischemic preconditioning can protect the heart from necrosis and reduce endo-enzyme leakage. The system of β-adrenergic signal transduction pathway probably takes part in the protection effect of the IP, which might be elicited by the PKA .
引用
收藏
页码:709 / 711 +714
页数:4
相关论文
共 50 条
  • [31] ALPHA-ADRENERGIC SIGNAL TRANSDUCTION IN MYOCARDIAL-CELL HYPOXIA
    KAGIYA, T
    KARLINER, JS
    ROCHASINGH, K
    HONBO, N
    CLINICAL RESEARCH, 1988, 36 (03): : A287 - A287
  • [32] Hyperbaric Oxygen Preconditioning Alleviates Myocardial Ischemic Injury in Rats
    Han, Cuihong
    Lin, Li
    Zhang, Weidong
    Zhang, Li
    Lv, Shijun
    Sun, Qiang
    Tao, Hengyi
    Zhang, John H.
    Sun, Xuejun
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2008, 233 (11) : 1448 - 1453
  • [33] Thermoregulation with age: Role of beta-adrenergic signal transduction
    Scarpace, PJ
    THERMOREGULATION: TENTH INTERNATIONAL SYMPOSIUM ON THE PHARMACOLOGY OF THERMOREGULATION, 1997, 813 : 111 - 116
  • [34] The Role of Neuroglobin in the Neuroprotection of Limb Ischemic Preconditioning in Rats
    Shu-Qin Li
    Wen-Bin Li
    Min Zhang
    Yu-Zhou Wu
    Yu-Yan Hu
    Molecular Neurobiology, 2013, 47 : 197 - 208
  • [35] The Role of Neuroglobin in the Neuroprotection of Limb Ischemic Preconditioning in Rats
    Li, Shu-Qin
    Li, Wen-Bin
    Zhang, Min
    Wu, Yu-Zhou
    Hu, Yu-Yan
    MOLECULAR NEUROBIOLOGY, 2013, 47 (01) : 197 - 208
  • [36] Signal trasduction pathway involved in the development of hepatic ischemic preconditioning.
    Carini, R
    De Cesaris, MG
    Spendore, R
    Vai, D
    Nitti, MP
    Paola, D
    Pronzato, MA
    Albano, E
    HEPATOLOGY, 2000, 32 (04) : 333A - 333A
  • [37] ADRENERGIC SIGNAL TRANSDUCTION IN THE KIDNEY
    JEFFRIES, WB
    PETTINGER, WA
    MINERAL AND ELECTROLYTE METABOLISM, 1989, 15 (1-2) : 5 - 15
  • [38] Adrenergic receptor signal transduction
    Kobilka, BK
    Gether, U
    STRUCTURE AND FUNCTION OF 7TM RECEPTORS, 1996, 39 : 171 - 179
  • [39] Increase of myocardial pHi by stretch:: the signal transduction pathway.
    Cingolani, HE
    Ennis, IL
    Alvarez, BV
    de Hurtado, MCC
    CIRCULATION, 1998, 98 (17) : 680 - 680
  • [40] ENHANCED BETA-ADRENERGIC SIGNAL TRANSDUCTION IN SPONTANEOUSLY HYPERTENSIVE RATS
    MAIE, S
    OHUSUZU, F
    KATSUSHIKA, S
    AKANUMA, M
    AOSAKI, N
    NAKAMURA, H
    OHASHI, H
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1991, 18 (09) : 671 - 673